Ravi Salgia, MD, PhD, discusses how to address and treat transformation from non–small cell lung cancer to small cell lung cancer.
Ravi Salgia, MD, PhD
Advertisement
Ravi Salgia, MD, PhD, is chair and professor in the department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center.
Articles by Ravi Salgia, MD, PhD
Ravi Salgia, MD, PhD, discusses the ways in which oncologists can watch out for non-small cell lung cancer that transforms to small-cell lung cancer.
Ravi Salgia, MD, PhD, discusses the results from a study of LB-100 combined with chemotherapy or immunotherapy to address transformation from non-small cell lung cancer to small cell lung cancer.
Advertisement
Latest Updated Articles
Key Signs of SCLC Transformation in Patients With EGFR+ NSCLCPublished: May 12th 2022 | Updated:
Examining Transformation of NSCLC to SCLC in EGFR+ DiseasePublished: April 19th 2022 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
